Silvana Salardi

Silvana Salardi

Auto-generated profile, based on publicly available information

Silvana Salardi

Department of Pediatrics, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2008 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
SSSilvana Salardi
Silvana Salardi
UVUmberto Volta
Umberto Volta
SZStefano Zucchini
Stefano Zucchini
EFErica Fiorini
Erica Fiorini
GMGiulio Maltoni
Giulio Maltoni
ACAlessandro Cicognani
Alessandro Cicognani

11 December 2003 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
SCSalvatore Cazzato
Salvatore Cazzato
FBFilippo Bernardi
Filippo Bernardi
SSSilvana Salardi
Silvana Salardi
DTDavide Tassinari
Davide Tassinari
ICIlaria Corsini
Ilaria Corsini
ECEmanuele Cacciari
Emanuele Cacciari

13 March 2012 in Diabetes Care
Verified
Journal Article
Open access
SSSilvana Salardi
Silvana Salardi
MPMassimo Porta
Massimo Porta
GMGiulio Maltoni
Giulio Maltoni
FRFlavia Rubbi
Flavia Rubbi
SRSilvia Rovere
Silvia Rovere
T(the Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology (ISPED)
the Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology (ISPED)
OBJECTIVE: To compare the effect of the prepubertal duration of diabetes on the occurrence of complications in two groups of patients after the same number of years of the disease. RESEARCH DESIGN AND METHODS: This multicenter study enrolled 105 patients aged 16–40.3 years; 53 were prepubertal at diagnosis (aged 0–3) and 52 were pubertal (Tanner stage) and aged 9–14.9. The mean duration of disease was 19.8 and 19.5 years for prepubertal and pubertal patients, respectively. In all patients, retinal photographs were taken and centrally graded. Urinary albumin excretion (UAE; 86 case subjects), blood pressure (BP; 89 case subjects), and lifetime HbA1c (72 case subjects) were also evaluated. RESULTS: The prevalence of diabetic retinopathy (DR) was higher in pubertal than in prepubertal patients, both for any grade DR (71 vs. 40%, P = 0.002) and for mild or more severe DR (P = 0.005). The prevalence of abnormal UAE was not different in the two groups. Hypertension was found only in three patients, all pubertal at diagnosis. In the small group with moderate-to-severe DR, lifetime HbA1c levels, as percentages above the upper normal reference value, were higher (P < 0.01) in prepubertal than in pubertal patients. CONCLUSIONS: If diabetes is diagnosed in infants or toddlers and the prepubertal duration of diabetes is very long, the patients seem to be protected against DR. This protection disappears if lifetime metabolic control is bad. Instead, when onset is at puberty, the DR risk is higher and less dependent on metabolic control and may be influenced by age-related factors, such as BP.

20 January 2011 in Diabetes Care
Verified
Journal Article
Open access
SSSilvana Salardi
Silvana Salardi
CBClaudia Balsamo
Claudia Balsamo
SZStefano Zucchini
Stefano Zucchini
GMGiulio Maltoni
Giulio Maltoni
MSMirella Scipione
Mirella Scipione
ACAlessandro Cicognani
Alessandro Cicognani
OBJECTIVE: To evaluate the frequency of normalization, the persistence of remission, and the impact on normalization of glycemic control and lipid profile, we analyzed data from a retrospective observational cohort study of type 1 diabetic children and adolescents with abnormal urinary albumin excretion (UAE). RESEARCH DESIGN AND METHODS: All diabetic children and adolescents (n = 41) who had persistent abnormal UAE in the period of 1984 to 2008 and followed up until 2009 (follow-up duration = 13.1 ± 6.2 years) were included in the study. Nine patients progressed to macroalbuminuria; 24 patients were administered ACE inhibitor treatment. RESULTS: The cumulative prevalence of abnormal UAE was 9%. During follow-up, 14 of 17 untreated and 19 of 24 treated patients reverted to normoalbuminuria. In the remission group compared with the nonremission group, A1C levels during follow-up decreased (7.5 ± 1.0 vs. 9.4 ± 1.2%, P < 0.0001) and serum HDL cholesterol increased (52.7 ± 11.3 vs. 42.7 ± 8.6 mg/dL, P < 0.05). The micro-macroalbuminuric patients had lower HDL cholesterol (51.0 ± 11.4 vs. 62.4 ± 13.6 mg/dL, P < 0.0001) than 134 normoalbuminuric diabetic patients. CONCLUSIONS: Microalbuminuria and macroalbuminuria were not permanent in most of our diabetic children and adolescents. If abnormal UAE values are high and persist for >1 year, only long-lasting treatment with ACE inhibitors seems able to induce persistent remission, especially when associated with good metabolic control and high HDL cholesterol levels.

21 June 2017 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
SSSilvana Salardi
Silvana Salardi
GMGiulio Maltoni
Giulio Maltoni
SZStefano Zucchini
Stefano Zucchini
DIDario Iafusco
Dario Iafusco
AZAngela Zanfardino
Angela Zanfardino
D(Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED)
Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED)

31 October 1987 in The Lancet
Verified
Journal Article
Closed access
UVUmberto Volta
Umberto Volta
CBClaudia Bonazzi
Claudia Bonazzi
EPEmilio Pisi
Emilio Pisi
SSSilvana Salardi
Silvana Salardi
ECEmanuele Cacciari
Emanuele Cacciari